AGL 38.31 Decreased By ▼ -0.25 (-0.65%)
AIRLINK 213.15 Increased By ▲ 5.38 (2.59%)
BOP 10.25 Increased By ▲ 0.19 (1.89%)
CNERGY 6.85 Decreased By ▼ -0.23 (-3.25%)
DCL 9.95 Decreased By ▼ -0.04 (-0.4%)
DFML 41.01 Decreased By ▼ -0.13 (-0.32%)
DGKC 103.88 Increased By ▲ 0.42 (0.41%)
FCCL 36.70 Increased By ▲ 0.35 (0.96%)
FFBL 91.90 Increased By ▲ 0.31 (0.34%)
FFL 14.17 Decreased By ▼ -0.43 (-2.95%)
HUBC 137.89 Decreased By ▼ -1.54 (-1.1%)
HUMNL 14.02 Decreased By ▼ -0.08 (-0.57%)
KEL 5.88 Decreased By ▼ -0.09 (-1.51%)
KOSM 7.29 Decreased By ▼ -0.57 (-7.25%)
MLCF 47.50 Increased By ▲ 0.22 (0.47%)
NBP 66.50 Decreased By ▼ -7.26 (-9.84%)
OGDC 223.74 Increased By ▲ 1.08 (0.49%)
PAEL 38.49 Increased By ▲ 0.38 (1%)
PIBTL 9.07 Decreased By ▼ -0.20 (-2.16%)
PPL 205.05 Decreased By ▼ -0.80 (-0.39%)
PRL 39.90 Increased By ▲ 0.05 (0.13%)
PTC 26.60 Decreased By ▼ -0.02 (-0.08%)
SEARL 107.70 Decreased By ▼ -2.54 (-2.3%)
TELE 9.35 Increased By ▲ 0.12 (1.3%)
TOMCL 38.10 Decreased By ▼ -0.11 (-0.29%)
TPLP 13.79 Increased By ▲ 0.02 (0.15%)
TREET 26.15 Decreased By ▼ -0.30 (-1.13%)
TRG 60.30 Decreased By ▼ -0.24 (-0.4%)
UNITY 33.78 Decreased By ▼ -0.36 (-1.05%)
WTL 1.79 Decreased By ▼ -0.09 (-4.79%)
BR100 12,280 Decreased By -18.5 (-0.15%)
BR30 38,734 Decreased By -143.3 (-0.37%)
KSE100 114,078 Decreased By -782.8 (-0.68%)
KSE30 35,943 Decreased By -253.2 (-0.7%)

Karandaaz Pakistan's latest study provides an in-depth analysis and evaluation of Pakistan's medical diagnostic equipment market for clinical laboratories that fall into the category of small and medium enterprises. It also includes an assessment of availability and need for formal financing.
'Market Analysis of Equipment for Clinical Laboratories and Availability of and Need for Formal Financing in Pakistan,' the study is aimed at providing the financial institutions with insights that will help them design new financial products or tailor existing ones to make them more responsive to demand and closely aligned with the financing requirements of small and medium enterprises operating in this segment.
It states that in 2017, the total value of diagnostic services within Pakistan's private sector was estimated to be between US$ 500 to $600 million with an expected growth rate of 15 percent over the next five years.
It suggest that nearly 15 million disease cases, in both the Punjab and Sindh provinces, have not been diagnosed despite patients' ability to afford such tests because of lack of ready diagnostic facilities. Initial assessment shows a huge potential exists for increased penetration of diagnostics services through private enterprises, especially among patients who can afford to pay for such services.
The unmet need of such facilities is primarily due to lack of access to finance for the sector, especially for formal local establishments and regional operators (such as Shifa, Sindh lab and Essa).
An assessment of the market shows the primary medical and diagnostic equipment market is very well-organised. It is dominated primarily by well-known multinational players that produce new or refurbished equipment that tends to have better technology and quality. Of the total equipment sold in the primary suppliers' market, 40-60 percent is refurbished and resold to new customers in the secondary market who have relatively limited budgets.
On the other hand, the secondary medical and diagnostic equipment market is driven by highly price-sensitive participants such as manufacturers, second-hand distributors who prefer buying second-hand equipment at very low scrap value.
This implies an appetite for short-term financing with a lower ticket size.
Mehr Shah, director of Knowledge Management and Communications at Karandaaz Pakistan said noted fast growing demand for diagnostic and lab equipment in Pakistan. And availability of financing has a direct impact on the proportion of demand that is met meaning growth of the sector.
To enable better understanding of this space from a financing perspective, the study identifies the types and brands of capital intensive, revenue generating equipment commonly used and its pricing in the primary and secondary market; the cost of repair and maintenance; the value chain in terms of vendors, importers and re-sellers in the primary and secondary markets and the financing arrangement at each stage of the value chain.
Citing a report, Ali Sarfraz, CEO Karandaaz said that according to the report, Pakistan has been ranked 6th among a total of 22 countries for the highest number of diseases in the world.
Through this publication, we hope to shed some light on many issues prevailing within the healthcare sector, particularly those pertaining to medical diagnostic equipment and trigger the interest of the entrepreneurs as well as formal financial sector for this industry, he said.
Sarfaraz further said this would have twofold dividends for Pakistan's economy. Not only will this catalyse economic growth and job creation but will also improve the medical diagnostics infrastructure that is needed to cope with the high burden of disease in Pakistan, he said.
Dr Shamshad Akhtar, chairperson Karandaaz said that overarching goal of the study is to provide financial institutions with an insight into the demand and economics of diagnostic and radiology equipment.
This can enable financial institutions to design new financial products or tailor existing ones that are more responsive to demand and are more closely aligned with the financing requirements for medical and diagnostic equipment by healthcare industry. Karandaaz, through such sector-specific studies, will continue to develop and disseminate evidence-based research insights into sectors that have a high potential for growth but have historically remained neglected by the formal financial sector.
Comparing Pakistan's diagnostic and imaging equipment market to other peer countries globally, the study found that the market is significantly under penetrated. Sales per capita of diagnostic and imaging equipment in Pakistan is $ 0.5, which is significantly diluted when compared to other developing Asian countries with relatively similar GDP per capita such as Vietnam and India whose sales per capita stands at $ 3.9 and $ 1.1, respectively.
Karandaaz promotes access to finance for small businesses through commercially directed investments and financial inclusion for individuals by employing technology-enabled digital solutions. The Karandaaz Pakistan has financial and institutional support from leading international development finance institutions, the United Kingdom Department for International Development (DFID) and the Bill & Melinda Gates Foundation.

Copyright Business Recorder, 2019

Comments

Comments are closed.